These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Postmenopausal hormone replacement therapy--is there a cause of worry?]. Skouby SO, Wilken-Jensen C, Jespersen J, Pedersen AT, Ottesen BS. Ugeskr Laeger; 2002 Aug 19; 164(34):3974-5. PubMed ID: 12212482 [No Abstract] [Full Text] [Related]
3. [Hormone therapy in climacteric. Different effects of estrogen and gestagen on the risk of breast and endometrial cancer]. Magnusson C, Weiderpass E. Lakartidningen; 2001 Jan 31; 98(5):418-21. PubMed ID: 11229082 [Abstract] [Full Text] [Related]
4. [Hormone replacement therapy in patients after breast cancer]. Köninger A, Kümmel S, Kimmig R. MMW Fortschr Med; 2008 Oct 23; 150(43):32-4. PubMed ID: 19025144 [No Abstract] [Full Text] [Related]
5. Latest on HRT & breast cancer risk. Johns Hopkins Med Lett Health After 50; 2000 May 23; 12(3):1-2. PubMed ID: 10798283 [No Abstract] [Full Text] [Related]
8. [Long-term hormone replacement and risk of breast carcinoma: current status. On behalf of the German Menopause Society and the Professional Society of Gynecologic Endocrinology and Reproductive Medicine of the German Society of Gynecology and Obstetrics]. Kuhl H, Runnebaum B, Schneider HP. Zentralbl Gynakol; 1995 May 23; 117(10):549-53. PubMed ID: 7491838 [No Abstract] [Full Text] [Related]
9. [Treatment with estrogen]. Ingelman-Sundberg A. Lakartidningen; 2002 Nov 21; 99(47):4777-8. PubMed ID: 12523062 [No Abstract] [Full Text] [Related]
10. [Health symptom-free women do not need preventive hormone replacement therapy. The risks outweigh the benefits; a large trial prematurely interrupted in the USA]. von Schoultz B. Lakartidningen; 2002 Aug 22; 99(34):3276-8. PubMed ID: 12362844 [No Abstract] [Full Text] [Related]
11. Timing of hormone therapy influences breast cancer risk. Harv Womens Health Watch; 2011 Apr 22; 18(8):7. PubMed ID: 21544975 [No Abstract] [Full Text] [Related]
15. [Increased risk of breast cancer following hormone replacement therapy during climacteric. 3 440 extra cases might have been caused by the treatment in Sweden during the 1990s]. Magnusson C, Reeves G. Lakartidningen; 2004 Feb 16; 102(16):1228-30. PubMed ID: 15921095 [No Abstract] [Full Text] [Related]
16. [Breast cancer and the use of the hormones around the menopause]. van der Mooren MJ, Kenemans P. Ned Tijdschr Geneeskd; 2004 May 15; 148(20):1009-10; author reply 1010-1. PubMed ID: 15181729 [No Abstract] [Full Text] [Related]
17. [Expert meeting on the effect of sex hormones on the normal breast: moderately increased risk of cancer, but the connection is still not clear]. von Schoultz B, Bergkvist L, Magnusson C, von Schoultz E. Lakartidningen; 2000 May 03; 97(18):2225-6. PubMed ID: 10850053 [No Abstract] [Full Text] [Related]
19. [Postmenopausal hormone therapy--an update. Benefit versus risk--important to identify women with increased breast cancer risk]. von Schoultz B. Lakartidningen; 2000 May 03; 106(34):2041-2. PubMed ID: 19769143 [No Abstract] [Full Text] [Related]
20. [Cancer and HRT--"now when the dust has settled"]. Krøll J. Ugeskr Laeger; 2004 Apr 05; 166(15-16):1465-6. PubMed ID: 15146821 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]